Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 88001-88050 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05053152
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
PHASE2
Recruiting
194 participants
Started: Apr 20, 2022 · Completed: Feb 1, 2029
5 conditions
2 sponsors
229 locations
NCT05985772
Operative vs Non-operative Management of Posterior-medial Meniscal Root Tears: A Randomized Multicenter Trial (RCT)
NA
Recruiting
140 participants
Started: Apr 20, 2022 · Completed: Mar 31, 2028
1 condition
2 sponsors
1 location
NCT05296161
B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis
PHASE4
Recruiting
296 participants
Started: Apr 20, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05271630
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
N/A
Active, not recruiting
69 participants
Started: Apr 20, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT05309551
Inspiratory Muscle Training Immediately After Lung Transplantation
NA
Active, not recruiting
90 participants
Started: Apr 20, 2022 · Completed: Feb 28, 2026
4 conditions
1 sponsor
1 location
NCT05282277
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
PHASE4
Recruiting
103 participants
Started: Apr 20, 2022 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
NCT04601064
Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care
NA
Recruiting
400 participants
Started: Apr 20, 2022 · Completed: Dec 15, 2026
6 conditions
2 sponsors
1 location
NCT04834427
Safety and Efficacy Evaluation of S (+) - Ketamine in Children
PHASE4
Enrolling by invitation
3,000 participants
Started: Apr 20, 2022 · Completed: Dec 4, 2024
9 conditions
5 sponsors
1 location
NCT05248191
FMT for Postop Crohn's Disease
PHASE1
Active, not recruiting
20 participants
Started: Apr 20, 2022 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT05199896
Touching the World With a Cane: Cognitive and Neural Processes
NA
Recruiting
300 participants
Started: Apr 20, 2022 · Completed: Oct 31, 2026
2 conditions
1 sponsor
1 location
NCT05342493
Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use
N/A
Recruiting
1,000 participants
Started: Apr 20, 2022 · Completed: Jun 22, 2029
1 condition
1 sponsor
1 location
NCT05376280
Nutritional Assessment in Non-tuberculous Mycobacteria Pulmonary Disease
N/A
Recruiting
120 participants
Started: Apr 20, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05291884
Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study
NA
Active, not recruiting
10 participants
Started: Apr 20, 2022 · Completed: Mar 31, 2028
2 conditions
1 sponsor
6 locations
NCT05232838
US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
NA
Active, not recruiting
50 participants
Started: Apr 20, 2022 · Completed: Jun 30, 2030
2 conditions
3 sponsors
11 locations
NCT05114850
Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®
N/A
Recruiting
450 participants
Started: Apr 20, 2022 · Completed: Dec 31, 2028
6 conditions
1 sponsor
28 locations
NCT05174650
Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements
PHASE2
Active, not recruiting
27 participants
Started: Apr 20, 2022 · Completed: Aug 31, 2026
1 condition
1 sponsor
17 locations
NCT05357963
Incidence of Chronic Pain After Sternotomy
N/A
Recruiting
200 participants
Started: Apr 20, 2022 · Completed: Aug 1, 2024
4 conditions
1 sponsor
1 location
NCT06200922
Telehealth in the Rehabilitation of Urinary Incontinence in Older Women
NA
Active, not recruiting
69 participants
Started: Apr 20, 2022 · Completed: Mar 20, 2024
1 condition
1 sponsor
1 location
NCT05352035
Multiomics Tumor Evolution Model of NSCLC
N/A
Recruiting
300 participants
Started: Apr 20, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT05275686
Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)
PHASE2
Recruiting
80 participants
Started: Apr 20, 2022 · Completed: Dec 31, 2025
1 condition
4 sponsors
4 locations
NCT05337826
The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes
NA
Active, not recruiting
122 participants
Started: Apr 20, 2022 · Completed: May 31, 2026
1 condition
3 sponsors
2 locations
NCT05029999
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
PHASE1
Recruiting
30 participants
Started: Apr 20, 2022 · Completed: Apr 20, 2026
2 conditions
4 sponsors
7 locations
NCT05240001
Thulium Fiber Laser (TFL) vs Holmium MOSES for Treatment of Benign Prostatic Hyperplasia (BPH)
NA
Recruiting
104 participants
Started: Apr 20, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05283512
Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease
NA
Recruiting
254 participants
Started: Apr 20, 2022 · Completed: Dec 31, 2027
4 conditions
10 sponsors
1 location
NCT04329065
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer
PHASE2
Recruiting
25 participants
Started: Apr 20, 2022 · Completed: Jun 30, 2027
3 conditions
2 sponsors
1 location
NCT05980585
Assessment of Heart Failure (HF) At-Home Management Solution ADI Cardio Pulmonary Monitoring System (CPM)
NA
Active, not recruiting
50 participants
Started: Apr 20, 2022 · Completed: Jun 1, 2025
1 condition
1 sponsor
1 location
NCT05348486
FMISO-based Adaptive Radiotherapy for Head and Neck Cancer
NA
Recruiting
120 participants
Started: Apr 20, 2022 · Completed: Jun 30, 2030
4 conditions
3 sponsors
3 locations
NCT06060548
Role of Novel ILR in the Management of PVCs
N/A
Recruiting
50 participants
Started: Apr 20, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
6 locations
NCT05127278
E-Detection Tool for Emerging Mental Disorders
N/A
Recruiting
3,000 participants
Started: Apr 20, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT05508347
Nituzumab (Taixinsheng ®) A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma
PHASE2
Recruiting
170 participants
Started: Apr 20, 2022 · Completed: Oct 30, 2027
1 condition
1 sponsor
1 location
NCT05313555
The Effect of Violet Device Dosed Ultra Violet-C Light (UV-C) Exposure on Healthy Hand Skin
NA
Active, not recruiting
30 participants
Started: Apr 19, 2022 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT05135715
A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)
PHASE2
Recruiting
50 participants
Started: Apr 19, 2022 · Completed: Dec 30, 2025
3 conditions
1 sponsor
4 locations
NCT05133661
SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study)
N/A
Active, not recruiting
17,602 participants
Started: Apr 19, 2022 · Completed: Dec 31, 2025
1 condition
4 sponsors
4 locations
NCT05211336
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System
PHASE1
Active, not recruiting
14 participants
Started: Apr 19, 2022 · Completed: Jun 1, 2029
2 conditions
1 sponsor
1 location
NCT04916613
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
PHASE3
Recruiting
300 participants
Started: Apr 19, 2022 · Completed: Sep 30, 2037
1 condition
2 sponsors
90 locations
NCT05103904
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
PHASE2
Recruiting
19 participants
Started: Apr 19, 2022 · Completed: Nov 4, 2026
8 conditions
3 sponsors
3 locations
NCT05445076
Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis
PHASE2
Active, not recruiting
250 participants
Started: Apr 19, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
2 locations
NCT05212571
Long-term Pain Modulation by Intravenous Esketamine in CRPS
NA
Enrolling by invitation
60 participants
Started: Apr 19, 2022 · Completed: Oct 1, 2027
2 conditions
1 sponsor
1 location
NCT05888064
Multi-parametric Imaging in Personalized Radiotherapy
N/A
Recruiting
35 participants
Started: Apr 19, 2022 · Completed: Aug 18, 2025
1 condition
2 sponsors
1 location
NCT05085496
Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC
PHASE1
Recruiting
12 participants
Started: Apr 19, 2022 · Completed: Sep 10, 2027
3 conditions
3 sponsors
1 location
NCT04945018
A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study)
PHASE1/PHASE2
Active, not recruiting
10 participants
Started: Apr 19, 2022 · Completed: Jan 31, 2026
2 conditions
1 sponsor
8 locations
NCT05232279
Effect of Testofen on Erectile Function in an Adult Male Population
PHASE3
Recruiting
120 participants
Started: Apr 19, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05314426
Mayo Clinic Phage Program Biobank
N/A
Enrolling by invitation
100 participants
Started: Apr 19, 2022 · Completed: Apr 30, 2027
1 condition
1 sponsor
1 location
NCT05028348
A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma
PHASE3
Recruiting
222 participants
Started: Apr 19, 2022 · Completed: Mar 31, 2029
1 condition
2 sponsors
94 locations
NCT05281809
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
PHASE2
Recruiting
30 participants
Started: Apr 19, 2022 · Completed: Dec 1, 2037
9 conditions
4 sponsors
1 location
NCT05369975
Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts
PHASE3
Active, not recruiting
225 participants
Started: Apr 19, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
22 locations
NCT04829877
Trajectory of Psychological Distress Among Infertility Women
NA
Recruiting
750 participants
Started: Apr 19, 2022 · Completed: Apr 30, 2025
3 conditions
1 sponsor
1 location
NCT05317247
Cough Audio Classification as a TB Triage Test
N/A
Recruiting
1,751 participants
Started: Apr 19, 2022 · Completed: Dec 30, 2027
1 condition
4 sponsors
2 locations
NCT05000515
"Inspiratory Muscle Strength Training for Lowering Blood Pressure and Improving Endothelial Function in Postmenopausal Women: Comparison With Standard of Care Aerobic Exercise"
NA
Recruiting
90 participants
Started: Apr 19, 2022 · Completed: Aug 1, 2026
4 conditions
1 sponsor
1 location
NCT03582514
PreOperative Brain Irradiation in Glioblastoma
PHASE1
Recruiting
18 participants
Started: Apr 19, 2022 · Completed: Jun 30, 2025
1 condition
5 sponsors
1 location
Previous
1
More pages
1758
1759
1760
1761
1762
1763
1764
More pages
2369
Next